Recent data demonstrate that inhibition of 3-hydroxy-3-methylglutaryl-CoA These data identify novel signaling changes in NPC, demonstrate the cholesterolsynthesis pathway is a likely source of CF-related cell signaling changes, and that cultured CF cells exhibit impaired cholesterol processing.
Introduction
Several studies indicate that inherent inflammatory cell signaling pathways exhibit altered regulation in CF epithelial cells. Our laboratory has identified altered expression of individual proteins mostly related to inflammatory signaling in CF epithelium including reduced expression of the inducible form of nitric oxide synthase (NOS2) (1) (2) (3) , reduced expression of SMAD3 (a transforming growth factor-β1 (TGF-β1) signaling protein) (4), altered regulation of signal transducer and activator of transcription-1 (STAT1) activity (5, 6) , and elevated expression of the small GTPase RhoA (7). Our overall hypothesis has been that each of these CF-related alterations is due to changes in a single process regulated by CFTR function that is capable of influencing a broad range of signaling interactions. We have recently demonstrated that STAT1 activation and NOS2 expression can be normalized in CF epithelial cells by interfering with isoprenoid/cholesterol synthesis by influencing RhoA signaling through (HMG-CoA) reductase inhibiton with mevastatin (7) . These data strongly implicate isoprenoid/cholesterol-dependent pathways as the triggering event in mediating altered CF cellular responses.
Niemann-Pick is primarily a neurological disease characterized by endosomal and lysomal accumulation of unesterified cholesterol and sphingomyelin (reviewed in 8).
There are multiple variations of Niemann-Pick disease that exhibit similar phenotypes.
Niemann-Pick Types A (NPA) and B (NPB) are the result of mutations in the gene for acid sphingomyelinase (ASM). NPA is characterized by an almost complete loss of ASM activity, whereas, NPB exhibits approximately a 90% reduction in ASM function.
Reduced ASM activity results in an accumulation of sphingomyelin and other lipids including unesterified cholesterol in endosomes and lysosomes. Niemann-Pick type C (NPC) is the direct result of impaired cholesterol transport due to gene mutations in NPC1 (9) . The hypothesis of this study is that CF cells and NPC fibroblasts share a common mechanistic lesion and should exhibit similar cell signaling alterations.
Circumstantial evidence based on disease phenotypes suggests the presence of some shared mechanisms between CF and NPC. In addition to neurological symptoms, one of the more pronounced phenotypes in NPC is excessive lipid accumulation in the liver and spleen leading to hepatosplenomegaly and progressive liver failure.
Interestingly, CF patients are also prone to developing hepatosplenomegaly, although this is typically attributed to ductal occlusion and only effects approximately 20% of patients (10) . However, at least one report describes CF liver disease as being characterized by excessive lysosomal accumulation of lipids (11) . In addition to hepatosplenomegaly, non-pulmonary radiographic features of Niemann-Pick disease include metacarpal widening and osteoporosis (12) , both secondary features of CF. CFTR is not expressed in the brain to any great extent accounting for a lack of CF-related neurological symptoms in CF. However, Niemann-Pick disease is characterized in part by severe pulmonary manifestations. A recent study examining the more rare form of NPC, NPC2, reported that six of seven patients followed in the study died of respiratory failure due to severe airway disease (13) . Pulmonary involvement has been reported in each type of Niemann-Pick disease, but airway disease appears to be more common in NPB and NPC2.
Data in this manuscript provide evidence of shared cell signaling regulatory mechanisms in cell models of NPC and CF. These data show that NPC and CF cell models share a number of cell-regulatory alterations including reduced NOS2 and SMAD3 expression, and elevated STAT1 and RhoA expression. Data also indicate that secondary effects of lost CFTR function influences normal cholesterol processing pathways.
Material and Methods
Cell Culture. Niemann-Pick fibroblasts (NPC) (GM03123A) containing two missense mutations in the NPC1 gene were obtained from Coriell Cell Repository (Camden, NJ). Acid Sphingomyelinase Assay. Amplex Red Acid Sphinogmyelinase (ASM) assay was obtained from Molecular Probe (Eugene, Oregon) and the protocol was followed accordingly on 9HTEo-cells using the 2-step ASM assay with 45 µg protein.
Fluorescence was measured using a Molecular Devices Fmax fluorescent plate reader. 
Real-time Reverse

Results
CF-like cell signaling alterations in NPC fibroblasts.
NOS2 induction. The observation of reduced NOS2 expression in the presence of apparently aggressive inflammatory signaling provides an intriguing insight into cell signaling alterations in CF cells (1) (2) (3) . We have previously demonstrated that altered NOS2 regulation was dependent on CFTR function (3), but how CFTR influences cell signaling is still unknown. To determine if impaired cholesterol regulation contributes to altered NOS2 expression, we examined Niemann Pick disease (NPC) as a model system.
As seen in CF cells, human NPC fibroblasts fail to induce NOS2 protein expression in response to cytomix (1ng/ml TNF-α, 0.5 mg/ml IL-1β, 100U/ml IFN-γ). However, robust NOS2 expression is seen in control wt fibroblasts in response to identical stimulation . However, no direct examination of these pathways have been performed in the S9/IB3 cell model. We examined RhoA and STAT1 porotein expression in these cell lines since these changes appear to be upstream in the signaling consequences related to cholesterol processing. As shown in figure 6 , STAT1 exhibits elevated expression in IB3 cells compared to CFTR-corrected S9 controls which is consistent with our other CF models. However, RhoA expression is robust in both IB3 and S9 cells suggesting that the partial correction of cholesterol esterification in S9 cells is insufficient to completely modulate RhoA regulation. These data do not address whether RhoA is constitutively active in S9 and IB3 cells as we have previously reported in mouse models of CF (7).
Further characterization of the ability of ectopic CFTR expression to influence cholesterol processing and related signaling cascades in CF cells is needed.
Potential mechanisms of increased filipin staining in CF model cells.
Acid Sphingomyelinase Activity. There are various forms of Niemann Pick disease, two of which are characterized as acid sphingomyelinase deficiencies that cause a secondary accumulation of lipids. Sphingomyelinase converts sphingomyelin to ceramide at the plasma membrane. To narrow the focus of a true model system and illuminate a possible mechanism of why and how de novo synthesis of cholesterol is up-regulated in CF cell models, acid sphingomyelinase activity was investigated using 9/HTEo-pCEP (control) and pCEPR (CF-phenotype) cells since filipin staining differences were more distinct in this model system. Two different experiments with a total of 8 samples for each cell type were averaged and reported in Figure 7 . There appears to be no significant difference in ASM activity between 9/HTEo-pCEPR (CF phenotype) and pCEP2 (control) cells. Two positive controls were used; one to measure sphingomyelinase from Straphyloccus sp and hydrogen peroxide to ensure the assay was functional. A negative control of reaction buffer was also measured and used to subtract background from each sample. This in vitro study implies that the acid sphingomyelinase is functional in CF cells and not the cause of the cholesterol accumulation seen with filipin staining. Significance determined by t-test and error bars represent SEM. Figure 7 .
NPC1 mRNA expression. NPC is caused by
